Recent Publications
Auxilius sees a business in transferring generics
Tadeusz Wesołowski — known among others as a shareholder of Neuca and Selvita — has just invested in a start-up that aims to modify generic drugs and register them in new markets.
The full text of the article is attached.
About chronic stable angina
Chronic stable angina pectoris is a type of angina that is characterised by recurring chest pain or discomfort. It occurs when there is reduced blood flow to the heart muscle due to narrowed or blocked coronary arteries. The chest pain in chronic stable angina is usually triggered by physical exertion or emotional stress and typically lasts for a few minutes.
GlobalData estimates that sales of the angina market (stable, microvascular, variant) to be approximately $7.8bn across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) in 2028. GlobalData is the parent company of the Clinical Trials Arena.
About Auxilius Pharma
Auxilius Pharma is a privately held pharmaceutical company that commenced operations in 2019. Auxilius operates in the space of value-added medicines and brings innovation to areas of high unmet need for patients with diseases such as chronic stable angina pectoris that aim to impact public health positively. Auxilius Pharma’s R&D Strategy is driven by patients' need for affordable medications to manage their chronic conditions in the US and on other major markets.